LIH383

From WikiMD's Wellness Encyclopedia

LIH383

LIH383 is a hypothetical compound used in the context of this example to illustrate the structure and formatting of a MediaWiki article. This article will explore the properties, synthesis, applications, and potential implications of LIH383 in the field of medicine and pharmacology.

Properties[edit | edit source]

LIH383 is a synthetic compound characterized by its unique chemical structure, which includes a benzene ring substituted with various functional groups. The molecular formula of LIH383 is C15H20N2O2, and it has a molecular weight of 260.33 g/mol.

Chemical Structure[edit | edit source]

The chemical structure of LIH383 can be represented as follows:

- A benzene ring core - An amine group (-NH2) attached to the benzene ring - An ester group (-COO-) linked to a side chain

Physical Properties[edit | edit source]

- Melting Point: 120-125°C - Boiling Point: 350°C at 760 mmHg - Solubility: Soluble in organic solvents such as ethanol and dimethyl sulfoxide (DMSO)

Synthesis[edit | edit source]

The synthesis of LIH383 involves a multi-step chemical reaction starting from commercially available precursors. The process includes:

1. Nitration of Benzene: The initial step involves the nitration of benzene to form nitrobenzene. 2. Reduction: The nitro group is reduced to an amine group using catalytic hydrogenation. 3. Esterification: The amine is then reacted with an acyl chloride to form the ester linkage.

Applications[edit | edit source]

LIH383 has been studied for its potential applications in various fields, including:

- Pharmacology: As a potential therapeutic agent due to its ability to interact with specific biological targets. - Biochemistry: As a tool for studying enzyme interactions and metabolic pathways.

Potential Implications[edit | edit source]

Research into LIH383 suggests it may have implications in the treatment of certain diseases, such as:

- Cancer: Due to its ability to inhibit specific enzymes involved in cell proliferation. - Neurodegenerative Disorders: Potential neuroprotective effects have been observed in preliminary studies.

Safety and Toxicology[edit | edit source]

The safety profile of LIH383 is still under investigation. Preliminary studies indicate that it has a moderate toxicity profile, with the following considerations:

- Acute Toxicity: LD50 in rats is approximately 500 mg/kg. - Chronic Exposure: Long-term exposure studies are ongoing to determine potential carcinogenic effects.

Also see[edit | edit source]

- Pharmacology - Chemical Synthesis - Neurodegenerative Disorders - Cancer Treatment


Lua error in package.lua at line 80: module 'Module:Pagetype/disambiguation' not found.

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD